JAM
KALA icon

Jupiter Asset Management’s KALA BIO KALA Stock Holding History

Jupiter Asset Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-70
Closed -$920K – 597
2021
Q2 		$920K Hold
70
– – 0.01% 444
2021
Q1 		$1.18M Buy
70
+17
+32% +$332K 0.01% 435
2020
Q4 		$896K Hold
53
– – 0.01% 470
2020
Q3 		$988K Buy
+53
New +$1.22M 0.01% 463

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Jupiter Asset Management's KALA Position: Q3 2021 in Review

Jupiter Asset Management sold out of KALA BIO (KALA) in Q3 2021, closing a stake of 70 shares — an estimated $920K sold.

Jupiter Asset Management first reported a position in KALA in Q3 2020 and held it in 4 quarters. The position peaked at $1.18M in Q1 2021. 99 funds tracked by Wall St. Rank hold KALA as of Q3 2021.

  • Jupiter Asset Management reported no remaining KALA BIO position as of Q3 2021 after selling out during the quarter.
  • Jupiter Asset Management sold 70 KALA BIO shares in Q3 2021, an estimated $920K.
  • Jupiter Asset Management first reported a position in KALA BIO in Q3 2020 and held it in 4 quarters.
  • Jupiter Asset Management's KALA BIO position peaked at $1.18M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held KALA BIO as of Q3 2021.

Based on Jupiter Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.